Prescribe to Save Lives

Not Applicable

Completed

• Conditions: Drug Overdose; Opioid-Related Disorders
• Interventions: Behavioral: Implementation intervention

• Registration Number: NCT03175640
• Lead Sponsor: Baystate Medical Center

Brief Summary

The U.S. is in the midst of an epidemic of opioid overdose deaths. The common use of opioids among persons living with HIV, along with their common use of benzodiazepines, has resulted in high rates of opioid overdose among this population. This study will test the implementation of evidence-based training, mentoring, technical support, and academic detailing to encourage HIV physicians to adopt evidence-based interventions to reduce overdose risk and treat opioid addiction.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2017-05-18
• Study First Submitted QC: 2017-06-02
• Study First Posted: 2017-06-05
• Study Start: 2017-07-12
• Primary Completion: 2019-12-31
• Study Completion: 2019-12-31
• Status Verified: 2020-12
• Last Update Submitted: 2020-12-17
• Last Update Posted: 2020-12-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 294

Inclusion Criteria

Clinicians and staff of HIV practice sites that:

• Receive Ryan White Funding;
• Treat adults with HIV;
• Have 3 or more prescribing clinicians;
• Have an electronic medical record (EMR) with an electronic medication list.

Read More

Exclusion Criteria

• Sites located in states with fewer than 500 Persons Living With HIV (PLWH) will be excluded

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Implementation intervention	Implementation intervention	-

Primary Outcome Measures

Name	Time	Method
Change in naloxone prescribing behavior	baseline to 6 months	Number of clinicians that prescribe naloxone. This information will be collected from electronic medical record (EMR) data.

Secondary Outcome Measures

Name	Time	Method
Change in perception about pharmacotherapy for opioid use disorder; 6-month	baseline to 6 months	Opinions About Medication Assisted Treatment (OAMAT) survey
Change in prescribing motivation; 6 months	baseline to 6 months	Change in Motivation Scale
Change in buprenorphine prescribing behavior	baseline to 12 months	Prevalence of buprenorphine prescription. This information will be collected from EMR data.
Change in prescriber training	baseline to 12 months	Number of prescribers that have completed buprenorphine training.
Change in perception about pharmacotherapy for opioid use disorder; 12-month	baseline to 12 months	Opinions About Medication Assisted Treatment (OAMAT) survey
Change in prescribing motivation; 12 months	baseline to 12 months	Change in Motivation Scale

Trial Locations

Locations (2)

University of Massachusetts Medical School - Baystate; 🇺🇸 Springfield, Massachusetts, United States

The Miriam Hospital; 🇺🇸 Providence, Rhode Island, United States